Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SevCov
NCT04355962Phase 3Completed
- Sponsor
- University of Zurich
- Start
- Apr 2020
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sevoflurane in coronavirus disease 2019 (COVID-19), acute respiratory distress syndrome (ARDS), sponsored by University of Zurich. Started Apr 2020; status: completed.
02
Drugs
sevoflurane
03
Conditions
coronavirus disease 2019 (COVID-19)acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT04355962.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04355962.